JAMA Neurology paper published today from ARC-HD Trial People with Huntington disease-associated chorea can safely convert overnight from tetrabenazine to deutetrabenazine (brand name: Austedo), according to the results of the Alternatives for Reducing Chorea in Huntington Disease (ARC-HD) trial published yesterday in JAMA Neurology.
Bloggers, Unite! - bloggersunite.netBloggers, Unite! - bloggersunite.net - The News and Times Blog - AI News Briefs - Audio Posts